Why the study?
Does MRI-detected delayed enhancement identify the risk of ventricular arrhythmias in patients with cardiac sarcoidosis and preserved or mildly reduced left ventricular function?
Population
Patients with cardiac sarcoidosis and preserved or mildly reduced left ventricular function
Comparison
Magnetic Resonance Imaging to assess for delayed… vs Patients without delayed enhancement (DE) on MRI
Design
Cohort
Authors
Loading...
RV DE on MRI may refine VT risk stratification in cardiac sarcoidosis with preserved LVEF; leaves open prospective validation before guiding therapy.
Does MRI-detected delayed enhancement identify the risk of ventricular arrhythmias in patients with cardiac sarcoidosis and preserved or mildly reduced left ventricular function?
MRI-detected delayed enhancement is a useful risk stratification tool for predicting ventricular arrhythmias in patients with cardiac sarcoidosis and preserved or mildly reduced ejection fraction.
Crawford et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: